Our news & events
Share

Lost in diagnostics for bovine respiratory disease: from rapid technological innovation to actionable information

Bart Pardon • UGent Calf Health; Clinic for Ruminants • Department of Internal Medicine, Reproduction and Population Medicine, Faculty of Veterinary Medicine, Ghent University

Abstract

Bovine respiratory disease (BRD) remains a major challenge for the cattle industry, particularly in the context of increasing demands for reduced antimicrobial use, improved animal welfare and sustainable production. At the same time, respiratory diagnostics are evolving rapidly, offering veterinarians an expanding range of tools. This article provides an overview of current and emerging diagnostic approaches for BRD and aims to help veterinarians select and apply them in a targeted and cost-effective manner. A stepwise diagnostic approach is proposed, combining early disease detection, lung ultrasonography, appropriate respiratory tract sampling and laboratory diagnostics. Sampling techniques and their indications are discussed, together with established and emerging laboratory methods, including bacterial culture, multiplex PCR, MALDI-TOF, nanopore sequencing and rapid point-of-care testing. Strategic pooling of samples can further improve cost-effectiveness at herd level. Rather than searching for a single optimal diagnostic test, test selection should be adapted to the clinical question, pathogen and herd context. Ultimately, diagnostic tests only provide data; their value and return on investment depend on the veterinarian’s ability to translate these data into targeted treatment, control and prevention measures.

Introduction

Respiratory diagnostics for cattle have never before been so extensive, accessible and affordable. At the same time, the context in which we need to use them has never been so demanding, with increasing challenges regarding antimicrobial use, animal welfare, economics and sustainable production. The rapid increase in the number of diagnostic tests, combined with a generally slower development of their correct interpretation and on-farm application, may possibly overwhelm veterinarians. The aim of this article is to provide an overview of diagnostic tests for bovine respiratory disease (BRD), discuss possibilities and limitations and come to some practical advice.

In transition

We live in interesting times, with unprecedented digitalisation and technological advancement occurring at a pace that is sometimes difficult to follow, but offering a glimpse of an improved future. Despite this, bovine respiratory disease is still a million-dollar challenge in the context of increasing consumer demands regarding antimicrobial use, animal welfare, environmental concerns and pressure to produce at low cost. Diagnostics are at the centre of the transition in BRD management that is currently taking place, aiming to finally make the step, in a responsible way, away from metaphylactic antimicrobial therapy towards individual therapy and a preventative approach. This transition needs to ensure that no additional production losses or animal welfare issues occur.

A few figures illustrate the scale of the problem. In a prospective study of 3,519 white veal calves in Belgium, 14.8% of calves were individually treated for BRD and pneumonia accounted for 27.1% of deaths. Mortality increased from 4.3% in calves not treated for BRD to 12.0% after one episode and 33.3% after three or more episodes, while hot carcass weight decreased by 8.2 kg after one episode and by 41.6 kg after three or more (Pardon et al., 2013). In dairy heifers, a meta-analysis showed that calfhood BRD is associated with 2.85 times higher odds of mortality, a 67 g/d lower average daily gain and 121 kg less milk in first lactation (Buczinski et al., 2021). Lung lesions detected by ultrasound also have a lasting impact: among 215 Holstein heifers followed during their first eight weeks of life, those with at least one episode of lung consolidation produced approximately 525 kg less milk over 305 days in first lactation (Dunn et al., 2018). In France, the association between pathogens and ultrasonographic lung lesions has also been described in young fattening bulls, highlighting in particular the role of bovine coronavirus (Rouault et al., 2024). Late identification weighs on these outcomes: in a large cohort of Californian dairy calves, 35 of the 52 calves that died from BRD had received only one treatment protocol, suggesting that disease was not identified early enough for treatment to be effective (Dubrovsky et al., 2020). Moreover, without identification of the primary pathogen involved, control measures remain generic rather than targeted.

Based on its research, UGent Calf Health proposes a step-by-step approach to BRD problems, which starts with an early warning, followed by lung ultrasonography (LUS) to map the problem and potentially already intervene medically. The third step is crucial, as it involves respiratory tract sampling and aetiological diagnostics. The final step uses information from laboratory diagnostics to tailor a pathogen-oriented approach, which, in a broad framework, differentiates herds with viral infections from Mycoplasma bovis herds and from herds in which only opportunistic infections (Pasteurellaceae) are found. The difference with the classic, so-called one-size-fits-all recommendations, mostly in the form of checklists or broad vaccination, is that based on the pathogen detected critical control points are identified and modified, thereby focusing farm resources where they may have the greatest return.

The trends in diagnostics in cattle medicine are clear and, like human medicine, point towards multiplex PCR panels, sequencing-based methods and rapid point-of-care testing. Adoption may be slower and unequally distributed due to costs, infrastructure, access to infrastructure and a lack of species-specific validation. This article aims to provide an overview of current and emerging diagnostic tools for BRD and to help veterinarians navigate rapid technological advances, enabling them to select and apply diagnostics in a targeted and cost-effective manner.

 A few words on thoracic ultrasound

Undoubtedly, over the last decade on farm thoracic ultrasound has become one of the most significant improvements in BRD management, with a high absorption capacity, meaning that it has potential to be applied across all types of cattle farming. It is consistently reported as the best diagnostic test, clearly outperforming clinical signs, especially when animals are assessed at a single time point (Lowie et al., 2022) (Buczinski et al., 2026). However, the fact that we do not yet see it appropriately applied on all farms, means that there are drawbacks. A major drawback is practical application, namely the need for a reliable scan technique that takes little time. The hurdles in training and the importance of certification have become clear, and with the UGent spin off company qTUS (www.qtus-vet.com) offering high-quality blended training sessions and certifying veterinarians for lung scanning, there is nothing besides willingness holding veterinarians back from applying it in the field. Classification tools such as the qTUS score help differentiate pneumonia cases, better estimate prognosis and even individualise antimicrobial therapy length duration, overall reducing antimicrobial use (Jourquin et al., 2025). However, with more users, more practical questions arise, especially regarding the timing of LUS. Strategic scanning moments, such as grouping or arrival, have been identified and successfully applied on farm. The ideal situation would actually be the integration of continuous sensor monitoring of behaviour, temperature or coughing, generating early warnings and providing lists of attention calves to the veterinarian performing the scans. This would ensure timely veterinary intervention. This is however still work in progress.

Another clear reality that has emerged both from research and from cases shared among qTUS users is that the outcome of antimicrobial or anti-inflammatory therapy differs depending on both the pathogen involved and host immunity (Jourquin et al., 2022, Jourquin et al., 2024, Motus et al., 2026). This is generally framed as ‘context matters’, and the message is that what happens at lung level and is seen with ultrasound can only be fully understood or predicted by using laboratory diagnostics to identify the pathogen(s) involved. This is why diagnostics are at the hub of both identifying cases suitable for therapy and developing tailor-made control and prevention measures.

Sampling

There are different ways to sample the respiratory tract in cattle, all with their pros and cons. Among these, the deep nasopharyngeal swab (DNS), transtracheal wash and non-endoscopic bronchoalveolar lavage (nBAL) are most frequently used (Pardon and Buczinski, 2020). Whereas DNS has advantages in terms of cost, procedural difficulty and animal friendliness, its use is mainly limited to identifying primary pathogens, in casu viruses and Mycoplasma bovis. An important point of attention is that the swab needs to be long enough to cover the distance from the nares to the medial canthus of the eye to sample the ciliated respiratory epithelium. There are interpretative issues when using DNS to investigate opportunistic bacterial infections (Pardon and Buczinski, 2020). For the latter purpose, a sample from the lower airways is needed. A transtracheal wash avoids potential contamination during passage through the nasal cavity but is limited to sampling around the tracheal bifurcation. This may represent the lung, but only if the mucociliary system is not impaired, which is often the case in pneumonia. In addition, there may be continuous aspiration of tracheopharyngeal opportunists.

The nBAL procedure is somewhat shorter and can be performed in an unsedated animal using commercial or custom-made catheters (eg. UGent nBAL catheter with outer diameter of 4mm and inner diameter of 2mm). The author likes to call it an ‘80/80% technique’, meaning that in approximately 80% of calves, the procedure results in an interpretable culture, being either a pure culture, dominant culture or negative culture. The other 20% are polymicrobial samples, which has been associated with a sampler effect (Van Driessche et al., 2017). So, here too, adequate training is key.

(R)evolution in laboratory diagnostic tests

An overview, with advantages, disadvantages and future prospects for diagnostics for respiratory tract infections is given in table 1. For decades, analysis of respiratory samples was limited to bacterial culture, mainly targeting Pasteurellaceae. Bacterial culture will remain necessary, especially for antimicrobial susceptibility testing, and typically takes about three days. Interpretation is not always straightforward, certainly with opportunists, but at least there is no discussion about viability. For M. bovis, conventional culture on PPLO agar is limited both in terms of time (a minimum of six days of incubation is needed) and sensitivity (Pardon and Buczinski, 2020). From the mid-2010s onwards, PCR became more widely available to practitioners, offering the advantage of testing for multiple pathogens at once, including viruses, with high sensitivity. However, interpretation of the detection of opportunistic pathogens is not straightforward, nor is estimating the infectious nature of the pathogen. In theory, PCR can be performed within a day, but in practice a turnaround time of three days is more common. Multiplex PCR is most commonly used, whereas the added value of quantitative PCR requires further research.

Next in the line of innovation was MALDI-TOF. The method identifies bacteria from cultures based on their protein fingerprint and has become standard in laboratories. MALDI-TOF can also be performed directly on samples or after a short incubation in enriched media. For M. bovis, a rapid method was developed, providing sensitivity and specificity both above 93.0%. The method is freely accessible and already offered by laboratories in several EU countries (Bokma et al., 2020, Bokma et al., 2021). The hallmarks of MALDI-TOF are speed and competitive pricing, with bacterial identification possible within hours after culture for Pasteurellaceae and in less than three days for M. bovis (Van Driessche et al., 2019) (Bokma et al., 2020). A rapid antibiogram has also been achieved using a MALDI-TOF method, named MBT-ASTRA, for oxytetracycline susceptibility in Pasteurella multocida in cattle, with near-perfect accuracy compared with microdilution (Van Driessche et al., 2018). Both direct detection and the possibility of obtaining an antibiogram make us dream of obtaining bacterial identification and an antibiogram within a single day. To the author's knowledge, the combination of both methods has not yet found its way into routine laboratories but is surely a future prospect.

The third innovation brought into practice over the last five years is nanopore sequencing (Oxford Nanopore Technologies). The method screens samples for the presence of DNA/RNA and thereby identifies the pathogens present. The major advantage is that the investigator no longer needs to specify which pathogens to test for. The method has been validated and is commercially available for respiratory viruses and Mycoplasma spp (Bokma et al., 2021). Sequencing also offers the possibility of strain typing, which may provide insights into biosecurity breaches or the expected efficacy of a vaccine against the circulating strain.

Despite not being a new laboratory test, the more frequent use of Bayesian statistics to evaluate diagnostic tests in cattle is a revolution. This method does not require a gold-standard reference test, resulting in more reliable estimates of sensitivity and specificity. For example, a study comparing PCR, nanopore sequencing and rapid MALDI-TOF for M. bovis detection in nBAL samples showed PCR to be sensitive but not always specific (cross-positivity), sequencing to be very specific but less sensitive, and MALDI-TOF to provide a more balanced combination of sensitivity and specificity (Bokma et al., 2021).

Whereas individual testing can be costly and provide only limited additional information at herd level, testing pooled samples (3–5 samples) may increase the likelihood of detecting the pathogens involved without losing sensitivity and specificity compared with individual testing (Bokma et al., 2021). To estimate where this evolution will take us next, we can learn from ongoing developments in human medicine towards broad multiplex (digital) PCR panels (syndromic panels; 15–25+ respiratory viruses and bacteria), sequencing-based methods—both targeted sequencing for a defined list of pathogens and metagenomic, hypothesis-free shotgun sequencing—and rapid point-of-care tests (LAMP, CRISPR-Cas). We should also not forget the impact of digitalisation and artificial intelligence, which will result in digital tools predicting the likelihood of a pathogen being involved in a given case based on data such as previous laboratory results, circumstantial evidence and national surveillance data (Lowie et al., 2021). In the EU DECIDE project, a cattle barometer was developed: a dashboard in which laboratories share test results, visualising spatiotemporal trends in respiratory pathogens (https://decideproject.eu/barometer). This open access information can be used by veterinarians and farmers for shared decision-making regarding vaccination and increased biosecurity measures, and by pharmaceutical compagnies to highlight the prevalence of the pathogens they have products for.

On-practice and point-of-care testing

Simultaneously with the positive developments in veterinary laboratories, there is a clear trend towards more testing within veterinary practices themselves (on-practice or in-clinic testing), as well as a desire for cow-side (point-of-care) testing. On-practice bacterial culture is commercially available for mastitis pathogens. It could also be used for respiratory pathogens but currently still faces hurdles such as more difficult phenotypic identification, the need for specific media (Mycoplasma spp.) and specific incubation conditions (CO₂ for Histophilus somni). In addition to culturing, the use of on-practice LAMP testing for mastitis pathogens has markedly increased in recent years, and test panels are becoming available for respiratory pathogens as well. LAMP (loop-mediated isothermal amplification) has the advantage that it can be performed at a single constant temperature, can use multiple primers and can provide a test result within an hour. Commercial devices are available and can handle either a single sample or up to five samples in a single run. In principle, the equipment can even be installed in a vehicle to provide on-farm services.

Published data on LAMP for BRD pathogens remain limited but encouraging. For M. bovis, a LAMP assay performed directly on 135 nasal swabs, without pre-culture, showed 97.2% sensitivity and 90.9% specificity, with a result within 60 minutes (Higa et al., 2016). For P. multocida, M. haemolytica and H. somni, a colorimetric LAMP assay was run on-farm on crude nasal swabs, without nucleic acid extraction, with a naked-eye readout within one hour; concordance with PCR, however, ranged from 60 to 100% depending on the pathogen, in a very small number of animals (n = 5) (Pascual-Garrigos et al., 2021). Extraction-free LAMP assays have also been developed for five respiratory viruses (BRSV, BPIV-3, BHV-1, BVDV-1 and bovine adenovirus 3), with an analytical sensitivity of 73–100% (Davidson et al., 2026). The strengths of LAMP therefore lie in its speed, tolerance to inhibitors, ability to work on minimally processed samples and simple equipment, enabling a result in practice, or even on-farm, during the visit. Pooled testing has proven valuable for other molecular methods (Bokma et al., 2021); for LAMP, pooling is currently limited to three samples and published data evaluating performance on pooled samples are still lacking. As for any new test, independent clinical validation, particularly on nBAL samples and under field conditions, remains necessary.[1]

Return on investment and test advice

Diagnostics can be costly; hence, one of the million-dollar questions for BRD is: what is the return on investment (ROI) of diagnostics? We need to differentiate between the likelihood that a sample–test combination will result in detection of the pathogen and what can actually be done with the information derived from the test in terms of control and preventive actions. Many factors affect the likelihood of detecting the pathogen. Of these, the veterinarian can influence appropriate animal selection, sampling technique, storage and transport, and selection of the laboratory performing the test. The veterinarian therefore holds a crucial position in ensuring ROI. Which animals to sample and which test to use is a frequently asked question to which my answer is: ‘It depends.’ There are sufficient indications for using each of the tests listed in table 1 in different scenarios, depending on whether the aim is a purchase examination, a culling decision, pathogen identification during an outbreak, etc. For the latter purpose, to ensure an acceptable likelihood of detecting the pathogens involved, the author recommends sampling five animals, which is statistically based on the detection-of-disease approach (Pardon and Buczinski, 2020). Selection criteria include the presence of lung consolidation and no antimicrobial or anti-inflammatory therapy in the previous 14 days. The presence of cough and/or fever is an additional criterion when available. Timing of sampling matters as well: after experimental BRSV infection, viral RNA remained detectable in nasal swabs for up to four weeks, whereas infectious virus was only isolated during the first two weeks (Klem et al., 2019). Sampling in the acute stage, which lung ultrasound now helps to identify earlier, therefore increases the likelihood of identifying the primary pathogen. In case of treatment failure, bacterial culture with antimicrobial susceptibility testing remains the most relevant tool to guide subsequent treatment. Beyond this, current evidence does not yet allow an optimal timing to be defined for each technology. To obtain a complete picture of the primary and opportunistic pathogens involved, we recommend to collect five nBAL samples. On each individual sample, culture for Pasteurellaceae and other opportunists is performed; M. bovis culture or rapid MALDI-TOF on the individual samples is optional. On a pooled sample from the five animals, either multiplex PCR, or nanopore sequencing or LAMP (limited to three samples) is performed to detect viruses and M. bovis. This approach helps to identify the primary pathogens involved and to better understand whether opportunistic superinfection has already occurred and whether a given bacterial species is dominant. If the interest lies in demonstrating that M. bovis is involved, for example as a condition for using metaphylaxis, PCR or rapid MALDI-TOF on a pool of five DNS samples may be the most cost-effective and animal-friendly approach. Context matters.

Returning to ROI and to what the potential value is of diagnostics. Diagnostics can aid in antimicrobial stewardship and through a pathogen-oriented approach may aid in focusing farm resources (financial and labor) to critical control points related to these specific pathogens or investing in the right vaccine. ROI should also not be limited to the farmer, as on-practice or cow-side testing may offer an interesting business model, in a food-animal practice with a shift away from medication sales towards test and consultancy honorarium. Anyway, both veterinarians and their clients need reliable, rapid and especially affordable diagnostics.

Finally, we need to realise that even the best diagnostic test just provides data. It is up to the veterinarian to transform these data into actionable information and, ultimately, effective interventions, hereby maximising the ROI of diagnostic tests. This requires education, hands-on training, certification and continued support.

Figure 1. Non-endoscopic bronchoalveolar lavage sampling in a calf with pneumonia by means of the custom-made UGent catheter (Teflon, 4mm outer, 2mm inner diameter).

Table 1. Overview of advantages and limitations of available diagnostic test for respiratory pathogens in cattle

Method

Pros

Cons

Likely future evolution

Bacterial culture (agar + biochemical ID or MALDI-TOF)

-Gold standard for viable, culturable isolates

-Antimicrobial susceptibility testing possible

-Inexpensive

-Information on mixed infections

-Slow (24-72h for antibiogram; > 6 days for Mycoplasma culture)

-Lower sensitivity

-Labor intensive

-Trained staff required

-Some pathogens grow poorer (false negatives; eg. Histophilus somni)

-No pooling

 

- Will remain important as reference method

- Increasingly combined with molecular methods

- Automation, e.g. with MALDI-TOF

Rapid (direct) MALDI-TOF

- Fast

-Low cost

-Good sensitivity (Se) and specificity (Sp)

-Pooling possible

-Expensive equipment (lab-based only)

-No identification of viruses

-High Se en Sp only for M. bovis

-Lower accuracy in polymicrobial and mixed samples (for Pasteurellaceae)

-Extension to other bacteria

-Antimicrobial resistance testing

-Improvement of diagnostic chain making identification and susceptibility test result available within a working day

PCR (conventional and multiplex)

-Fast (hours-same day possible)

-High sensitivity and specificity

-Detect non-culturable bacteria

-Test multiple pathogens (viruses and bacteria) in a single run

-Pooling possible

- More expensive

- Detects ‘dead DNA’ (interpretation issues)

- Sensitive to inhibiters

- No strain typing

- Limited to predefined targets

- Specialised equipment and trained staff needed

- Often takes 3 days under real-live conditions

- Expected to remain the most frequently used test

- Can evolve to syndromic panels with digital PCR

- Inclusion of antimicrobial resistance markers

- Integration of quantitative results

Next Generation Sequencing (NGS) (targeted (tNGS) or metagenomic (mNGS)

-Broad spectrum, without predefined panel

-No live organisms required

-Detects non-culturable pathogens

-Enables resistance genome profiling

-Mapping of co-infections

-Microbiome studies

-Strain typing

-Very high specificity

-Pooling possible

-More expensive

-More complex interpretation (trained staff and extensive database)

- Longer turnaround time possible

-Lower Se compared to PCR possible

-Only for pathogen identification in routine diagnostics available

-Antibiogram not yet available

-Often takes more than a day (3 for M. bovis)

-Further development in sub-products

-Likely larger role in research

-Beter pipelines in diagnostic laboratories

-Development of microbiome tests

-Integration with inflammatory profiles (host)

LAMP

-Very fast; often within the hour

-Isothermal, can run on compact readers (lower cost)

-High Se; tolerant of inhibitors

-Simple workflow, on-practice possible by non-laboratory staff

-Limited to fixed panel

-Risk of contamination

-Also detects ‘dead DNA’ (interpretation)

-External validation pending

-Expected to expand further as on-practice or even car/barn test

-More multiplex LAMP systems

-Inclusion of resistance genes

 


Explore our ruminant range of tests


References

Bokma, J., et al. (2020). "Rapid Identification of Mycoplasma bovis Strains from Bovine Bronchoalveolar Lavage Fluid with Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry after Enrichment Procedure." Journal of Clinical Microbiology 58(6).

Bokma, J., et al. (2021). "Evaluation of nanopore sequencing as a diagnostic tool for the rapid identification of Mycoplasma bovis from individual and pooled respiratory tract samples." Journal of Clinical Microbiology: JCM0111021.

Buczinski, S., D. Achard and E. Timsit (2021). "Effects of calfhood respiratory disease on health and performance of dairy cattle: A systematic review and meta-analysis." Journal of Dairy Science 104(7): 8214–8227.

Buczinski, S., et al. (2026). "Lung ultrasonography used as a diagnostic test for respiratory disease diagnosis in calves: Systematic review and meta-analysis using a Bayesian latent-class modeling approach." Journal of Dairy Science 109(8): 8748–8765.

Davidson, J. L., et al. (2026). "Detection of five viruses commonly implicated with bovine respiratory disease using loop-mediated isothermal amplification." Veterinary Quarterly 46(1). doi:10.1080/01652176.2025.2607418.

Dubrovsky, S. A., et al. (2020). "Preweaning cost of bovine respiratory disease (BRD) and cost-benefit of implementation of preventative measures in calves on California dairies: The BRD 10K study." Journal of Dairy Science 103(2): 1583–1597.

Dunn, T. R., et al. (2018). "The effect of lung consolidation, as determined by ultrasonography, on first-lactation milk production in Holstein dairy calves." Journal of Dairy Science 101(6): 5404–5410.

Higa, Y., et al. (2016). "An improved loop-mediated isothermal amplification assay for the detection of Mycoplasma bovis." Journal of Veterinary Medical Science 78(8): 1343–1346.

Jourquin, S., et al. (2022). "Randomized field trial comparing the efficacy of florfenicol and oxytetracycline in a natural outbreak of calf pneumonia using lung reaeration as a cure criterion." Journal of Veterinary Internal Medicine 36(2): 820–828.

Jourquin, S., et al. (2024). "Non-inferiority trial in veal calves on the efficacy of oxytetracycline and florfenicol treatment for pneumonia guided by quick thoracic ultrasound." Journal of Dairy Science 108(2); 1896-1916.

Jourquin, S., et al. (2025). "Development of a classification system for lung ultrasonographic findings in calves based on the association with cure and production outcomes." Journal of Dairy Science 108(7): 7452–7471.

Klem, T. B., et al. (2019). "Bovine respiratory syncytial virus in experimentally exposed and rechallenged calves; viral shedding related to clinical signs and the potential for transmission." BMC Veterinary Research 15: 156.

Lowie, T., et al. (2021). "Decision tree analysis for pathogen identification based on circumstantial factors in outbreaks of bovine respiratory disease in calves." Preventive Veterinary Medicine 196: 105469

Lowie, T., et al. (2022). "Differences in the association of cough and other clinical signs with ultrasonographic lung consolidation in dairy, veal, and beef calves." Journal of Dairy Science 105(7): 6111–6124.

Motus, K., et al. (2026). "Longitudinal dynamics and recovery of lung ultrasonographic consolidations, association with growth in dairy calves in herds with circulating bovine coronavirus and Pasteurellaceae." Journal of Dairy Science 109(8): 8766–8783.

Pardon, B., et al. (2013). "Impact of respiratory disease, diarrhea, otitis and arthritis on mortality and carcass traits in white veal calves." BMC Veterinary Research 9: 79.

Pardon, B. and S. Buczinski (2020). "Bovine Respiratory Disease Diagnosis: What Progress Has Been Made in Infectious Diagnosis?" Vet Clin North Am Food Anim Pract 36(2): 425–444.

Pascual-Garrigos, A., et al. (2021). "On-farm colorimetric detection of Pasteurella multocida, Mannheimia haemolytica, and Histophilus somni in crude bovine nasal samples." Veterinary Research 52: 126.

Rouault, M., G. Foucras, F. Meurens, C. Toczé and S. Assié (2024). "Association des agents pathogènes avec les lésions pulmonaires échographiques des jeunes bovins en engraissement : place du coronavirus bovin." Journées nationales des Groupements techniques vétérinaires (JNGTV): 579–584.

Van Driessche, L., et al. (2017). "A Deep Nasopharyngeal Swab Versus Nonendoscopic Bronchoalveolar Lavage for Isolation of Bacterial Pathogens from Preweaned Calves With Respiratory Disease." Journal of Veterinary Internal Medicine 31(3): 946–953.

Van Driessche, L., et al. (2018). "Rapid detection of tetracycline resistance in bovine Pasteurella multocida isolates by MALDI Biotyper antibiotic susceptibility test rapid assay (MBT-ASTRA)." Scientific Reports 8 (1) 13599.

Van Driessche, L., et al. (2019). "Rapid identification of respiratory bacterial pathogens from bronchoalveolar lavage fluid in cattle by MALDI-TOF MS." Sci Rep 9(1): 18381.            


 [1]Bart, I found no peer-reviewed data on LAMP with three pooled samples; the 3-sample limit is taken from your ROI section. Please adapt or remove the pooling sentence if you consider it insufficiently supported.

Stay
Informed

Event

Enalees participation in international scientific congresses 2024

Throughout the year, Enalees takes part in the main conferences in the field of diagnostics, so that we can meet you, talk to you and present our results through posters and lectures!Here is a list of...

Scientific newsletter

Enalees launches new Rhéa® respiratory panel: a new clinical reference for LAMP PCR diagnosis of respiratory diseases in livestock

Enalees launches new Rhéa® respiratory panel: a new clinical reference for LAMP PCR diagnosis of respiratory diseases in livestock ...

Feline respiratory diagnostics with Mycoplasma felis panel | Enalees
Press release

Enalees strengthens its feline respiratory diagnostics offer with a panel incorporating Mycoplasma felis

Enalees strengthens its feline respiratory diagnostics offer with a panel incorporating Mycoplasma felis...

Feline coronavirus (FCoV) | Diagnosis| Enalees
Scientific newsletter

Feline coronavirus

Feline coronavirus (FCoV) is widespread among cats and may progress to feline infectious peritonitis (FIP). Learn why rapid molecular diagnosis matters....

Animal welfare & veterinary diagnosis | Enalees
Case Studies

MANAGEMENT OF ANIMAL WELFARE AND APPROPRIATE TREATMENT AT Oniris

Discover how rapid molecular diagnostics support animal welfare by enabling earlier and more appropriate treatment decisions....

SUBSCRIBE TO OURNEWSLETTER

Receive our latest news, exclusive offers and expert advice straight to your inbox. Sign up so you don't miss a thing!

Cart
Your cart is empty.